PREMADIX

Preparing market introduction of DN-X-PRO - a breakthrough solution for real-time studies of DNA-protein interactions at single-molecule resolution

 Coordinatore STICHTING VU-VUMC 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 163˙000 €
 EC contributo 150˙000 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2013-PoC
 Funding Scheme CSA-SA(POC)
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-12-01   -   2014-11-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    STICHTING VU-VUMC

 Organization address address: DE BOELELAAN 1105
city: AMSTERDAM
postcode: 1081 HV

contact info
Titolo: Dr.
Nome: Yvonne
Cognome: Kops
Email: send email
Telefono: +31 205987893

NL (AMSTERDAM) hostInstitution 150˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cellular    team    protein    resolution    dna    business    premadix    date    environment       strategy    dn    super    pro   

 Obiettivo del progetto (Objective)

'Through ERC-funded research, Prof. Wuite developed the DN-X-PRO as a method and instrument that enables direct visualization of DNA-protein interactions in real-time, at the single-molecule level, at super-resolution, under conditions similar to the cellular environment. Using the DN-X-PRO, researchers can manipulate and measure mechanical and structural properties of DNA-protein complexes, while simultaneously localizing individual proteins on the DNA, with nanometer accuracy and super-resolution. To date, such studies can only be performed by separate application of two or three different instruments, in conditions that do not resemble the cellular environment, with lower resolution. This results in a strong proposition to biomolecular researcher labs worldwide, allowing conduct of a range of experiments that are very complicated or not possible to date. The PREMADIX project will result in a clear valorization strategy — based on elemental business insights that permit estimation of commercial and financial feasibility and business modeling and planning. Besides, a sound intellectual property (IP) strategy will be defined. In parallel, the DN-X-PRO will be physically prepared for marketing, translating the current prototype into a robust and user-friendly design accompanied by product sheets, control and analysis software, and user manuals. Finally, the PREMADIX team will assemble a business team, and start discussions with potential strategic partners and financers. By doing so, at the end of PREMADIX, the team will have strong assets for market introduction.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

REBOOT (2014)

Releasing the brakes on adult plasticity

Read More  

ANTINEUTRINONOVA (2012)

Probing Fundamental Physics with Antineutrinos at the NOvA Experiment

Read More  

ENHREG (2013)

Exploring enhancers’ Achilles Heel

Read More